HM1.24—utilizing cancer vaccines
US8652839B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 30, 2003 |
| Grant date | Feb 18, 2014 |
| Priority date | — |
| Expiry date | Oct 27, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cancer vaccine containing as an active ingredient an antigen-specific dendritic cell pulsed by an HM1.24 protein, HM1.24 peptide or transduced with an HM1.24-encoding gene, or HM1.24 protein-encoding DNA or RNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.